paroxysmal tonic upgaze

Paroxysmal tonic upgaze is a rare neurological condition, overwhelmingly seen in infants and young children, in which the eyes suddenly lock in an upward position for seconds to minutes at a time. The child typically tilts the chin downward as if compensating, and the episodes can repeat dozens of times a day before stopping on their own, often within a few years. First described in 1988, PTU was long considered completely harmless, but that picture has grown more complicated as research has uncovered genetic links and developmental concerns in a meaningful share of affected children.

What an Episode Actually Looks Like

During a typical PTU episode, a child’s eyes deviate upward in a sustained, conjugate manner, meaning both eyes roll up together. The child often flexes the neck, tucking the chin down, which appears to be an instinctive attempt to keep looking forward despite the upward deviation. Horizontal eye movements remain intact, so the child can still look side to side normally. When trying to look down, the eyes produce jerky, downbeat saccades rather than smooth movement. Critically, the child stays fully conscious throughout. There is no stiffening, shaking, or loss of awareness. Episodes last from a few seconds to around twenty seconds, crop up in clusters or in isolation, and can happen many times per day.

1PubMed Central. Paroxysmal tonic upgaze accompanied by occipital discharge on electroencephalography: a case report and literature review

Beyond the eye movements, some children show accompanying facial features during a bout. One documented case described raised eyebrows, a slightly lowered jaw, closed lips, and a faint grin. In other children the episodes look more subtle, with only the upward gaze standing out. The variability in presentation is part of what makes PTU confusing for parents and sometimes for clinicians.

Triggers and Timing

Parents often notice that episodes are worse at certain times of day or under particular conditions. Fatigue is the most consistently reported trigger. As a child gets drowsy or tired, episodes ramp up in frequency and intensity. Conversely, sleep reliably shuts them down. Once the child falls asleep, the upward deviation stops entirely until they wake again.

2Pediatric Neurology Briefs. Paroxysmal Tonic Upgaze: Age of Onset and Prognosis

Febrile illnesses are another recognized aggravator. When children with PTU develop a fever, the episodes tend to become more frequent and sometimes more prolonged.

3Brain and Development. Paroxysmal tonic upgaze of childhood–a review

This pattern of worsening with fatigue and fever, and resolving with sleep, is characteristic enough that it can actually help distinguish PTU from other conditions. Epileptic seizures, for instance, can occur during sleep, and oculogyric crises from medication reactions tend not to follow a fatigue-related rhythm. If a parent reports that the eye episodes always vanish when the child naps, that is a meaningful diagnostic clue.

How Doctors Figure Out What It Is

PTU is primarily a clinical diagnosis, meaning doctors identify it based on the pattern of symptoms rather than a single definitive lab test. The workup usually includes a neurological examination, brain MRI, electroencephalogram (EEG), and metabolic screening. In most cases of classic PTU, these tests come back normal. The MRI shows no structural brain abnormality, and the EEG shows no epileptic activity.

4PubMed. Paroxysmal Tonic Upgaze in Children: Three Case Reports and a Review of the Literature

Video recording is enormously helpful. Because episodes are brief and unpredictable, a neurologist may never see one during an office visit. Parents who capture episodes on a smartphone give clinicians a direct look at the eye movements, the compensatory head posture, and the preserved consciousness. Video-EEG monitoring, where the child’s brain waves and behavior are recorded simultaneously, can confirm that the upward gaze episodes do not correlate with epileptic discharges.

The most important thing doctors are trying to rule out is epilepsy, because the episodes can superficially resemble certain seizure types. Absence seizures, for example, involve brief lapses in awareness, and some epileptic events include eye deviation. The key difference is that children with PTU remain fully alert and responsive during episodes, and the EEG stays normal. That said, in rare cases PTU and epileptic activity can coexist, making the picture murkier.

Conditions That Can Look Similar

Oculogyric crisis is the condition most commonly confused with PTU. It also involves sustained upward deviation of both eyes, but it arises from a different mechanism. Oculogyric crises are a form of acute dystonia and are associated with medications like antipsychotics and antiemetics, as well as with neurometabolic and neurodegenerative disorders.

5PubMed Central. Spotlight on Oculogyric Crisis: A Review

The practical difference matters. PTU episodes are brief, cluster throughout the day, and follow a pattern tied to fatigue and wakefulness. Oculogyric crises tend to be longer, sometimes lasting minutes to hours, and are often accompanied by other dystonic movements like neck extension or jaw clenching. If a child is on any medication known to trigger dystonic reactions, that history immediately shifts the differential away from PTU.

Other conditions in the differential include opsoclonus (rapid, chaotic eye movements rather than a sustained upward lock), infantile spasms (which involve characteristic EEG patterns and body movements), and vertical gaze palsy from brainstem lesions. In one reported case, a child with PTU-like episodes turned out to have demyelinating lesions in the brainstem, and the episodes resolved after corticosteroid treatment.

6Journal of Child Neurology. Paroxysmal Tonic Upgaze Presenting as a Clinical Isolated Syndrome

Genetics and the CACNA1A Connection

For years, PTU had no known genetic basis. That changed when researchers began finding mutations in the CACNA1A gene in some affected children. This gene encodes a calcium channel protein that plays a central role in how neurons in the brain communicate, and mutations in it are already linked to a family of neurological conditions including episodic ataxia type 2, familial hemiplegic migraine, and spinocerebellar ataxia type 6.

In one key study, genetic sequencing in three children with PTU revealed three different de novo mutations in CACNA1A, meaning the mutations were new in those children and not inherited from carrier parents.

7PubMed. Paroxysmal tonic upward gaze as a presentation of de-novo mutations in CACNA1A

Another study of a nine-month-old boy with PTU and associated ataxia confirmed CACNA1A involvement and found the child responded well to acetazolamide, a drug already used in other CACNA1A-related conditions.

8PubMed Central. Pearls & Oy-sters: CACNA1A-Related Paroxysmal Tonic Upgaze With Ataxia Responsive to Acetazolamide

The CACNA1A link is significant for a couple of reasons. It gives clinicians a concrete genetic target to test for when they suspect PTU, and it opens the door to more targeted treatment. But not all children with PTU carry CACNA1A mutations. The condition appears genetically heterogeneous, and researchers suspect other genes are involved that have not yet been identified. Some cases also show familial clustering without an identified mutation, suggesting additional genetic contributors remain undiscovered.

What Is Happening in the Brain

The exact brain circuitry behind PTU is not fully mapped, but there are strong clues. Vertical eye movements are controlled by specific brainstem nuclei. Upward gaze, in particular, relies on circuits running through the midbrain, and the way the brain generates and holds vertical eye positions involves coordinated activity between multiple small neural clusters. When something disrupts that coordination, sustained upward deviation is one possible result.

There is also evidence pointing to the dopamine system. Both PTU and Angelman syndrome, a neurodevelopmental condition, have been linked to abnormalities in dopaminergic neurons. Researchers have speculated that the dopaminergic dysfunction present in Angelman syndrome could be what triggers PTU in children who have both conditions.

9PubMed. Paroxysmal tonic upward gaze complicating Angelman syndrome

The dopamine connection also helps explain why levodopa, a dopamine precursor drug, has shown benefit in some PTU cases. If the episodes stem at least partly from inadequate dopaminergic signaling in the circuits that control vertical gaze, boosting dopamine levels could ease the problem. Still, this is more of a working hypothesis than a settled explanation. The involvement of CACNA1A calcium channels suggests that multiple neurotransmitter systems and ion-channel pathways can converge on the same clinical picture.

Treatment Options

Many children with PTU are never treated with medication because the episodes resolve on their own over time. For those with frequent or disruptive episodes, or when PTU is accompanied by ataxia or developmental concerns, a few pharmacological options have shown promise.

Levodopa, the same drug used in Parkinson disease, was among the earliest treatments reported to help. In early case series, it showed clear benefit in reducing episodes.

10Developmental Medicine & Child Neurology. Benign Paroxysmal Tonic Upgaze of Childhood With Ataxia, A Neuroophthalmological Syndrome of Familial Origin?

More recently, carbonic anhydrase inhibitors have emerged as a promising class of treatment. In a study of five children treated with either acetazolamide or sultiame, all showed at least partial improvement. This held true regardless of the underlying cause or specific genetic variant, suggesting that carbonic anhydrase inhibition addresses something fundamental about the mechanism rather than just one pathway.

11PubMed. Paroxysmal tonic upgaze: A heterogeneous clinical condition responsive to carbonic anhydrase inhibition

The fact that acetazolamide works across different subtypes of PTU is encouraging, especially for clinicians who may not have genetic testing results in hand. It also aligns with what is known about acetazolamide’s effectiveness in other episodic neurological conditions like episodic ataxia type 2, further reinforcing the CACNA1A overlap.

One case report also documented improvement with dimenhydrinate (sold under the brand name Gravol), an over-the-counter motion sickness medication with anticholinergic properties. The episodes in that child were likewise worse with fatigue and improved with sleep, following the typical PTU pattern.

12Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. Successful treatment of paroxysmal tonic upgaze with low dose Gravol ®

There is no single standard treatment protocol. Decisions are made case by case depending on how severe and frequent the episodes are, whether ataxia or other neurological features are present, and what the genetic workup shows. Parents are usually reassured that the episodes themselves are not dangerous and that many children outgrow them.

The Question of Whether PTU Is Really Benign

When PTU was first described, the word “benign” was part of the name. The original case series highlighted normal investigations, eventual improvement, and no neurological deterioration. As more cases were followed long-term, that reassuring picture turned out to be too simple.

A reappraisal published in the Annals of Neurology followed 16 children with PTU and found that roughly two-thirds had developmental delay, intellectual disability, or language delay at follow-up. Over half had ocular motility problems beyond PTU itself. Only about one in five children ended up with completely normal development and neurological findings. The authors argued that PTU is a heterogeneous syndrome that may be an early, age-dependent sign of broader neurological dysfunction rather than an isolated, harmless quirk.

13Annals of Neurology. Paroxysmal tonic upgaze: A reappraisal of outcome

A later study reinforced these concerns but with somewhat less alarming numbers. In that cohort, psychomotor delay was found in about 19% of patients, abnormal neurological examination in 32%, and low or borderline IQ in roughly a quarter. Cognitive dysfunction overall affected about 27%. Carrying a CACNA1A mutation was significantly associated with both the tonic upgaze episodes and cognitive dysfunction.

14Developmental Medicine & Child Neurology. Benign paroxysmal torticollis, benign paroxysmal vertigo, and benign tonic upward gaze are not benign disorders

The discrepancy between the two studies likely reflects differences in how patients were selected and followed. The earlier reappraisal included children referred to a specialist center, which tends to capture more severe cases. The later study cast a wider net. Either way, the message is consistent: PTU is not automatically benign, and affected children deserve developmental monitoring even if the eye episodes themselves are improving.

When PTU Appears Alongside Other Conditions

PTU does not always appear in isolation. Ataxia, or unsteadiness in walking and coordination, is one of the most common accompaniments. The original case descriptions noted varying degrees of ataxia, and the CACNA1A link makes this association easy to understand, since CACNA1A mutations are independently associated with episodic ataxia.

15PubMed Central. Pearls & Oy-sters: CACNA1A-Related Paroxysmal Tonic Upgaze With Ataxia Responsive to Acetazolamide

Some children with Angelman syndrome, a genetic condition characterized by developmental delay and movement abnormalities, also develop PTU episodes. That overlap has contributed to the hypothesis that dopamine-system dysfunction is one of the pathways leading to the upward gaze phenomenon.

16PubMed. Paroxysmal tonic upward gaze complicating Angelman syndrome

In rarer situations, PTU-like episodes have appeared in the context of demyelinating disease, where the immune system attacks the insulating coating of nerve fibers in the brain. In one case, a child’s PTU episodes and corresponding brain lesions both resolved with corticosteroid treatment, suggesting the upward gaze was a downstream effect of inflammation rather than the primary problem.

17Journal of Child Neurology. Paroxysmal Tonic Upgaze Presenting as a Clinical Isolated Syndrome

These overlapping presentations reinforce the idea that PTU is better thought of as a symptom pattern than a single disease. Multiple different disruptions to the brainstem and midbrain circuits controlling vertical gaze can produce the same outward appearance. Figuring out which disruption is at play matters because it determines the prognosis and the best treatment approach.

What Parents Should Watch For

If your child has been diagnosed with PTU, the episodes themselves are not harmful in the moment. The child remains conscious, is not in pain, and the episodes stop on their own. Most families find that keeping a log of episodes, including time of day, duration, and what the child was doing, helps the neurologist track trends and decide whether treatment is warranted.

The more important concern is developmental monitoring. Given the evidence that a substantial fraction of children with PTU go on to show delays in language, cognition, or motor skills, regular developmental assessments are worth doing even if the eye episodes seem to be fading. Early intervention services for speech or motor skills can make a real difference if delays are caught early.

Genetic testing for CACNA1A is increasingly part of the workup, especially when PTU appears alongside ataxia or when episodes are severe. A positive result does not change the immediate management much, but it does inform expectations about the child’s broader neurological trajectory and can guide the choice of medication. It also provides families with information that could be relevant for future pregnancies, though most identified CACNA1A mutations in PTU have been de novo rather than inherited.

How Many Children Are Affected

PTU is genuinely rare. As of a comprehensive review in the early 2000s, only about 49 cases had been reported in the medical literature worldwide.

18Brain and Development. Paroxysmal tonic upgaze of childhood–a review

The number of published cases has grown since then, but PTU remains uncommon enough that many pediatricians and even some neurologists have never encountered it. That unfamiliarity contributes to diagnostic delays. Parents may go through multiple emergency department visits, rounds of EEG testing, and even trials of anti-seizure medication before a clinician recognizes the pattern. The condition’s rarity also means there are no large randomized trials of treatment. Nearly everything known about pharmacological management comes from case reports and small case series, which is typical for rare pediatric neurological conditions but means the evidence base, while growing, remains limited.